Upon successful completion of these requirements,
you will receive a printable credit statement.
If you have any
questions about this process, please email
the Center for Continuing and Outreach
Education at email@example.com or call CCOE Enrollment Services at (800) 227-4852.
Provided by François-Xavier Bagnoud Center, School of Nursing, Rutgers, The State University of New Jersey and the Center for Continuing and Outreach Education at Rutgers Biomedical and Health Sciences.
This activity is supported by an educational grant from the New Jersey Department of Health (NJDOH)—Division of HIV, STD and TB Services, through an MOA titled “Education and Training for Physicians and other Healthcare Professionals in the Diagnosis and Treatment of HIV/AIDS.”
Statement of Need
Over the past 3 years, new recommendations have been made for the primary care immunization of persons living with HIV (PLWH) by the Infectious Diseases Society of America (2013) and the Centers for Disease Control and Prevention (2014). Specific immunization recommendations have been made for children, adolescents, and adults with HIV-infection. These recommendations include: use of the pneumococcal 13-valent protein conjugate vaccine (PCV13) for persons >6 years in addition to the 23-valent pneumococcal polysaccharide vaccine (PPSV23) with a booster dose of the PPSV23 five years after the initial PPSV23 dose. Because PLWH are at increased risk of pneumococcal pneumonia, it is essential that adequate immunization of PLWH occur and that booster vaccinations are given as recommended in national guidelines.
In addition to pneumococcal vaccinations, influenza vaccinations are recommended annually for persons living with HIV without contraindications ages >6 months. In the United States, influenza results in significant morbidity and mortality which could have been prevented due to vaccination. These recommendations are in addition to those for other FDA approved vaccinations for infants, children, adolescents, and adults.
This activity will assist health care providers with implementation of current recommendations for immunizing persons of all ages living with HIV against preventable diseases.
This activity is designed for physicians, physician assistants, advanced practice nurses, nurses and health educators, and other health care professionals in New Jersey who are involved in the care of people infected with HIV and their non-HIV infected partners.
Method of Participation
Participants should read the learning objectives, review the activity in its entirety, and then complete the self-assessment test, which consists of a series of multiple-choice questions. Upon completing this activity as designed and achieving a passing score of 70% or more on the self-assessment test and submitting a course evaluation, participants will receive a printable credit statement.
Upon completion of this activity, participants should be able to:
- Describe recommendations for use of select inactivated and live vaccines for the pediatric to geriatric HIV-infected population
- Identify other vaccinations (primary and booster) needed by adolescents and adults living with HIV who have had their primary childhood vaccinations.
Activity Director/CE Academic Advisor
Shobha Swaminathan, MD, Assistant Professor, Division of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School
Connie Calisti-Myers, JD, Assistant Commissioner, NJDOH-Division of HIV, STD and TB Services
John Nelson, PhD, CPNP, Program Director, AETC NRC, FXB Center, Rutgers
Andrea Norberg, MS, RN, Executive Director,
FXB Center, Rutgers
Michelle Thompson, Program Manager,
FXB Center, Rutgers
Elizabeth Ward, MSJ, Executive Director, Rutgers CCOE
Sima S. Toussi, MD,
Assistant Professor of Pediatrics,
Weill Cornell Medical College
Patricia DeLaMora, MD,
Associate Professor of Pediatrics,
Weill Cornell Medical College
Harjot K. Singh, MD, ScM,
Assistant Professor of Medicine,
Weill Cornell Medical College
Rutgers, The State University of New Jersey is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Rutgers, The State University of New Jersey designates this enduring material for a maximum of 0.75 AMA PRA Category Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Rutgers, The State University of New Jersey, Center for Continuing and Outreach Education is an approved provider of continuing nursing education by the New Jersey State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Provider Number P173-05/31/2016.
This activity is awarded 1.02 contact hours (60 minute CH).
Rutgers Center for Continuing and Outreach Education certifies that this continuing education offering meets the criteria for up to .1 Continuing Education Units (CEUs), provided the activity is completed as designed. One CEU equals 10 contact hours of participation in an organized continuing education experience under responsible sponsorship, capable direction and qualified instruction. Participants should only claim those contact hours actually spent participating in the activity.
In order to help ensure content objectivity, independence, and fair balance, and to ensure that the content is aligned with the interest of the public, CCOE has resolved all potential and real conflicts of interest through content review by a non-conflicted, qualified reviewer. This activity was peer-reviewed for relevance, accuracy of content and balance of presentation by John Nelson, PhD, CPNP.
This activity was field tested for time required for participation by Noa’a Shimoni, MD, MPH, David Abel, DO, Howard A. Grossman, MD, Anna M. Haywood, MSN, RN, Juanita Howell, MSN, RN, and Laura Bogert, BSN, RN.
In accordance with the disclosure policies of Rutgers University and to conform with ACCME and FDA guidelines, individuals in a position to control the content of this educational activity are required to disclose to the activity participants: 1) the existence of any relevant financial relationship with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, with the exemption of non-profit or government organizations and non-health care related companies, within the past 12 months; and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/ device not yet approved.
Harjot Kaur Singh, MD is a member of the Scientific Advisory Board for Gilead Sciences.
Shobha Swaminathan, MD receives grant /research support from Gilead Sciences.
All other authors, planning committee members, peer reviewers and field testers have no relevant financial relationships to disclose.
Off-Label Usage Disclosure
This activity does not contain information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of NJDOH – Division of HIV, STD and TB Services, any manufacturer of pharmaceuticals or devices, or Rutgers University. It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
Copyright © 2015 Rutgers University
All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission in writing from Rutgers University.
Please direct CE related or technical questions to Rutgers at 973-972-4267 or email firstname.lastname@example.org.